Luteinizing hormone–releasing hormone antagonists in prostate cancer

This publication has 9 references indexed in Scilit:

• Biochemical Outcome Following External Beam Radiation Therapy With or Without Androgen Suppression Therapy for Clinically Localized Prostate Cancer
  JAMA, 2000
• Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer
  New England Journal of Medicine, 1998
• LHRH Antagonists
  Published by Springer Nature ,1998
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord
  Urology, 1995
• Responses to the antagonistic analog of LH-RH (SB-75, cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer
  The Prostate, 1994
• A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
  New England Journal of Medicine, 1989
• New antagonists of LHRH II. Inhibition and potentiation of LHRH by closely related analogues
  International Journal of Peptide and Protein Research, 1988
• Synthetic Polypeptide Antagonists of the Hypothalamic Luteinizing Hormone Releasing Factor
  Science, 1972